Concepedia

Alison Kennedy

AK

Statistics

Publications

11

Citations

896

H-Index

10

Active since

2016

Affiliations

University of Oxford(Current)

MRC Weatherall Institute of Molecular Medicine

University of Birmingham

Oxford University Hospitals NHS Trust

Nuffield Orthopaedic Centre

Alison Kennedy is an author at University of Oxford specializing in medicine, molecular oncology, and chemotherapy.

ORCID

Publications per year

2016–2024

11

Publications

11

Clonal heterogeneity of acute myeloid leukemia treated with the IDH2 inhibitor enasidenib

Lynn Quek, Muriel D. David, Alison Kennedy et al. · Nature Medicine · 2018 · 200 citations · Full text

, , +16

Genetically distinct leukemic stem cells in human CD34− acute myeloid leukemia are arrested at a hemopoietic precursor-like stage

Lynn Quek, Georg Otto, Catherine Garnett et al. · The Journal of Experimental Medicine · 2016 · 148 citations · Full text

, , +17

Mechanisms of Progression of Myeloid Preleukemia to Transformed Myeloid Leukemia in Children with Down Syndrome

Maurice Labuhn, Kelly Perkins, Sören Matzk et al. · Cancer Cell · 2019 · 145 citations · Full text

, , +15

Selective advantage of mutant stem cells in human clonal hematopoiesis is associated with attenuated response to inflammation and aging

Niels Asger Jakobsen, Sven Turkalj, Andy G.X. Zeng et al. · Cell stem cell · 2024 · 98 citations · Full text

, , +17

Outcome of Azacitidine Therapy in Acute Myeloid Leukemia Is not Improved by Concurrent Vorinostat Therapy but Is Predicted by a Diagnostic Molecular Signature

Charles Craddock, Aimee E. Houlton, Lynn Quek et al. · Clinical Cancer Research · 2017 · 86 citations · Full text

, , +13

1–5 of 11